Showing results (101-110 of 109) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Diabetes & Vascular Disease Research|October 20, 2022
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosisElisabeth B Stougaard, Peter L Kristensen, Urd Kielgast, et al.Journal of Diabetes and Its Complications|May 6, 2022
Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) studyIsabella Melena, Federica Piani, Kalie L Tommerdahl, et al.Plos Medicine|April 27, 2022
Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysisBenjamin Speich, Dmitry Gryaznov, Jason W Busse, et al.Diabetes Care|December 28, 2023
Insulin Secretion, Sensitivity, and Kidney Function in Young Individuals With Type 2 DiabetesPetter Bjornstad, Ye Ji Choi, Carson Platnick, et al.Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Role of endogenous adenine in kidney failure and mortality with diabetesKumar Sharma, Guanshi Zhang, Jens Hansen, et al.The New England Journal of Medicine|November 4, 2022
Empagliflozin in Patients with Chronic Kidney Disease, William G Herrington, Natalie Staplin, et al.The Journal of Clinical Investigation|August 24, 2023
Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patientsKumar Sharma, Guanshi Zhang, Jens Hansen, et al.BMJ Open|February 26, 2026
Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysisLuxcia Kugathasan, Massimo Nardone, Marcel Muskiet, et al.The Canadian Journal of Cardiology|February 11, 2020
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in AmyloidosisEileen O'Meara, Michael McDonald, Michael Chan, et al.Pageof 11